Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 71.46% is in line with its 5-year average of 76.75%, around the middle of its 5-year range (45.67%–86.85%).
As of the fiscal period ended Saturday, July 4, 2026. 3.04% below its 12-month average of 73.70%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-07-04): 71.46%.
DEBT TO ASSETS RATIO
71.46%
DEBT TO ASSETS RATIO AVG TTM
73.70%
DEBT TO ASSETS RATIO AVG 3Y
78.85%
DEBT TO ASSETS RATIO AVG 5Y
76.75%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-3.04%
CURRENT VS 3Y AVG
-9.36%
CURRENT VS 5Y AVG
-6.89%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.11%
median of 517 covered companies
CURRENT VS SECTOR MEDIAN
+64866.79%
vs the sector median at left
Aveanna Healthcare Holdings Inc.
Market Cap
$2.74B
Debt to Assets Ratio
71.46%
TTM Avg
73.70%
3Y Avg
78.85%
5Y Avg
76.75%
Market Cap
$2.68B
Debt to Assets Ratio
0.46%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.69B
Debt to Assets Ratio
0.13%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.76B
Debt to Assets Ratio
0.18%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.53B
Debt to Assets Ratio
0.05%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.89B
Debt to Assets Ratio
0.02%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.90B
Debt to Assets Ratio
0.59%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aveanna Healthcare Holdings Inc. (AVAH) | $2.74B | 71.46% | 73.70% | 78.85% | 76.75% |
| Acadia Healthcare Company, Inc. (ACHC)vs › | $2.68B | 0.46% | N/A | N/A | N/A |
| Alamar Biosciences, Inc. (ALMR)vs › | $2.69B | 0.13% | N/A | N/A | N/A |
| Beam Therapeutics Inc. (BEAM)vs › | $2.76B | 0.18% | N/A | N/A | N/A |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.53B | 0.05% | N/A | N/A | N/A |
| AtriCure, Inc. (ATRC)vs › | $2.85B | 0.11% | N/A | N/A | N/A |
| Dyne Therapeutics, Inc. (DYN)vs › | $2.89B | 0.02% | N/A | N/A | N/A |
| TransMedics Group, Inc. (TMDX)vs › | $2.90B | 0.59% | N/A | N/A | N/A |
| Disc Medicine, Inc. (IRON)vs › | $2.45B | 0.08% | N/A | N/A | N/A |
| Clover Health Investments, Corp. (CLOV)vs › | $2.43B | 0.00% | N/A | N/A | N/A |
Debt/Assets
71.5%
Debt/Equity
5.24
Current Ratio
1.16
Interest Coverage
1.9x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-07-04 | 71.46% |
| 2026-04-04 | 74.30% |
| 2026-01-03 | 74.76% |
| 2025-09-27 | 74.29% |
| 2025-06-28 | 84.21% |
| 2025-03-29 | 79.72% |
| 2024-12-28 | 80.15% |
| 2024-09-28 | 81.08% |
| 2024-06-29 | 80.19% |
| 2024-03-30 | 81.49% |
| 2023-12-30 | 83.34% |
| 2023-09-30 | 81.18% |
| 2023-07-01 | 77.24% |
| 2023-04-01 | 86.85% |
| 2022-12-31 | 79.18% |
| 2022-10-01 | 68.35% |
| 2022-07-02 | 68.16% |
| 2022-04-02 | 54.35% |
| 2022-01-01 | 55.62% |
| 2021-10-02 | 45.67% |
| 2021-07-03 | 45.84% |
| 2021-04-03 | 68.16% |
| 2020-12-31 | 66.62% |
